By Editorial Staff
June 01, 2026
For decades, the public perception of the BRCA gene mutation has been tethered almost exclusively to breast and ovarian cancer. The "pink ribbon" narrative, while successful in raising awareness for women’s health, has inadvertently created a blind spot: the role of men. However, as the medical community increasingly understands the genetic landscape of hereditary cancers, it is becoming clear that BRCA is not a "women’s issue." It is a family issue—one that requires men to be proactive participants in their own health and the health of their lineages.
Doug Bank, a veteran cancer advocate and member of the Sharsheret Men’s Leadership Council, knows this reality intimately. His journey—from a testicular cancer survivor to a BRCA2 mutation carrier—highlights a critical shift in how we approach hereditary oncology.
The Chronology of a Genetic Legacy
Doug Bank’s path to understanding his genetic risk was not a straight line. It began in his youth, with a diagnosis that seemed disconnected from his later reality.
- 1990s: At age 26, Bank was diagnosed with Stage I testicular cancer. At the time, the diagnosis was treated as an isolated event, though the aggressive nature of the recommended treatment spurred him to seek secondary opinions and advocate for his own care. This experience served as the catalyst for his long-term involvement in cancer advocacy.
- Early 2000s: While working with the LIVESTRONG Young Adult Alliance, Bank connected with Rochelle Shoretz, the visionary founder of Sharsheret, an organization dedicated to supporting women facing breast and ovarian cancer. At the time, the connection felt professional, not personal.
- 2009: Following a series of cancer diagnoses within his extended family—including his father’s prostate cancer and multiple cases of breast and ovarian cancer among cousins—Bank underwent genetic testing. The results confirmed he carried a BRCA2 mutation.
- The Mid-2010s: The gravity of the mutation manifested in Bank’s own family. His brother was diagnosed with pancreatic cancer, a condition strongly linked to the BRCA2 mutation.
- 2020s: Bank’s daughter, having tested positive for the BRCA2 mutation, discovered a lump in her breast at age 24. Because her risk was already established and monitored, she received immediate, life-saving intervention.
- 2026: Bank himself was diagnosed with prostate cancer at age 56, underscoring the ongoing, multi-generational impact of the BRCA2 mutation.
Understanding the BRCA Mutation in Men
The BRCA1 and BRCA2 genes are tumor suppressors. When they function normally, they repair damaged DNA. When they are mutated, however, that repair mechanism fails, allowing cancer cells to proliferate.
While the risk of breast cancer in men is significantly lower than in women, it is not zero. Men with a BRCA2 mutation have a roughly 7% lifetime risk of developing breast cancer, compared to roughly 0.1% for the general male population. Furthermore, the BRCA2 mutation is a well-established driver of aggressive prostate cancer and has been linked to an increased risk of pancreatic cancer and melanoma.
The "Missing Link" Syndrome
Men often serve as the "silent carriers" of hereditary risk. Because men do not undergo the same routine screenings for breast or ovarian cancer as women, they may harbor a mutation for decades without knowing it. By the time a man is diagnosed with a related cancer, he may have already passed the mutation to his children, effectively losing a critical window for early detection and preventative care.
Supporting Data: Why Pedigree Matters
Medical experts emphasize the importance of the "pedigree," or a detailed family health history. Bank’s story illustrates why: when he finally mapped his family’s cancer history, the patterns were impossible to ignore.
According to data from the National Cancer Institute (NCI), individuals who have a first-degree relative (parent, sibling, or child) with a known BRCA mutation have a 50% chance of carrying the same mutation. Yet, many men remain hesitant to pursue testing due to a combination of social stigma, a "tough it out" mentality, and a lack of awareness regarding their own risk profiles.
The medical community is now shifting toward a more inclusive screening model. Guidelines increasingly suggest that men with a significant family history of cancer—especially those with a known BRCA mutation in the family—should consult with a genetic counselor.
Official Perspectives: The Role of Organizations Like Sharsheret
While Sharsheret was founded to support women, its evolution reflects the growing understanding that cancer is a family-wide challenge. Organizations like Sharsheret now provide essential resources for men who are navigating the emotional and physical complexities of being "BRCA-positive."
"Knowledge is power," Bank notes, reflecting on his daughter’s experience. Had his family not known about the mutation, his daughter’s breast lump might have been dismissed as a benign issue due to her age. Instead, her medical team was prepared, vigilant, and ready to act.
The Medical Consensus on Genetic Testing
Genetic counselors and oncologists emphasize three key takeaways for men:
- Testing is not just for the patient: Genetic testing provides a roadmap for the entire family. If a man tests positive, his siblings, parents, and children have a clearer path to determining their own health risks.
- Anxiety vs. Empowerment: While the prospect of testing can trigger anxiety, it is a finite, manageable stress compared to the potential for late-stage cancer discovery.
- Proactive Monitoring: For men who test positive for a BRCA mutation, clinicians often recommend earlier and more frequent prostate cancer screenings, as well as increased vigilance regarding other associated cancers.
The Broader Implications: Redefining Men’s Health
The inclusion of men in the BRCA conversation is not merely a matter of health equity; it is a clinical necessity. The "wait-and-see" approach to hereditary cancer has proven fatal for too many families. By integrating men into the screening, testing, and support frameworks, we can catch mutations before they manifest as advanced-stage disease.
The story of Doug Bank serves as both a warning and a testament to the power of genetic literacy. When men step out from the periphery and into the center of these health discussions, they change the trajectory of their families’ futures.
Moving Forward
For men wondering if they should be tested, the process is straightforward but requires a proactive mindset:
- Document your history: Write down every cancer diagnosis in your family, including the age of diagnosis and the specific type of cancer.
- Consult a genetic counselor: These professionals are trained to interpret complex family trees and advise on whether formal genetic testing is appropriate.
- Engage the family: Open communication is the most effective tool against the secrecy that often surrounds hereditary diseases.
As the field of precision medicine advances, the stigma surrounding genetic mutations is slowly being replaced by the necessity of informed action. Men possess the power to be the gatekeepers of their own health and the health of the generations that follow. It is time for the conversation to become as inclusive as the risk itself.
About the Author
